GlaxoSmithKline: shares down after broker cuts target price.
(CercleFinance.com) - Shares in GlaxoSmithKline are down today, after UBS cut its target price for the share from 1,600 pence to 1,550 pence, while maintaining a "neutral" rating on the stock.
GSK shares are currently down 0.5% at 1,515 pence, while the FTSE 100 index is up 0.1%. The stock has fallen by 3% so far this year.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
GSK shares are currently down 0.5% at 1,515 pence, while the FTSE 100 index is up 0.1%. The stock has fallen by 3% so far this year.
Copyright (c) 2017 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.